Literature DB >> 15139501

IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior.

Itta M Minderhoud1, Bas Oldenburg, Josta A Wismeijer, Gerard P van Berge Henegouwen, André J P M Smout.   

Abstract

The aim of this study was to assess the prevalence of irritable bowel syndrome-like symptoms in healthy controls and inflammatory bowel disease patients in remission using the Rome II criteria. Furthermore, the possible relation of irritable bowel syndrome-like symptoms with the quality of life and coping behavior was studied. Seventy-three ulcerative colitis patients in remission, 34 Crohn's disease patients in remission, and 66 healthy controls completed questionnaires on irritable bowel syndrome, quality of life, and coping. Using the Rome II criteria, irritable bowel syndrome-like symptoms were found in one-third of ulcerative colitis patients and in 42% of Crohn's disease patients in remission. The presence of irritable bowel syndrome-like symptoms impaired the quality of life of patients, while no relation was found between the presence of symptoms and coping strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15139501     DOI: 10.1023/b:ddas.0000020506.84248.f9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Optimism and adaptation to multiple sclerosis: what does optimism mean?

Authors:  M Fournier; D de Ridder; J Bensing
Journal:  J Behav Med       Date:  1999-08

2.  Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease.

Authors:  M G Russel; C J Pastoor; S Brandon; J Rijken; L G Engels; D M van der Heijde; R W Stockbrügger
Journal:  Digestion       Date:  1997       Impact factor: 3.216

Review 3.  Trauma and the gut: interactions between stressful experience and intestinal function.

Authors:  R Stam; L M Akkermans; V M Wiegant
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

4.  Predictors of health care seeking for irritable bowel syndrome: a population based study.

Authors:  N J Talley; P M Boyce; M Jones
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Effects of appendicectomy on the course of ulcerative colitis.

Authors:  J Cosnes; F Carbonnel; L Beaugerie; A Blain; D Reijasse; J-P Gendre
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

6.  Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Authors:  Magnus Simrén; Jenny Axelsson; Rolf Gillberg; Hasse Abrahamsson; Jan Svedlund; Einar S Björnsson
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Epidemiology of colonic symptoms and the irritable bowel syndrome.

Authors:  N J Talley; A R Zinsmeister; C Van Dyke; L J Melton
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

9.  Prevalence of gastrointestinal symptoms in the elderly: a population-based study.

Authors:  N J Talley; E A O'Keefe; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

10.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

View more
  64 in total

1.  Irritable bowel syndrome--the main recommendations.

Authors:  Viola Andresen; Jutta Keller; Christian Pehl; Michael Schemann; Jan Preiss; Peter Layer
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission.

Authors:  Lilani P Perera; Ashwin N Ananthakrishnan; Corinne Guilday; Kristin Remshak; Yelena Zadvornova; Amar S Naik; Daniel J Stein; Benson T Massey
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

Review 3.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 4.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

Review 5.  Exercise and inflammatory bowel disease.

Authors:  Neeraj Narula; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

Review 6.  Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

7.  Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients.

Authors:  Arvind I Srinath; Alka Goyal; Lori A Zimmerman; Melissa C Newara; Margaret A Kirshner; Francis Nicole McCarthy; David Keljo; David Binion; Athos Bousvaros; David R DeMaso; Ada Youk; Eva M Szigethy
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

8.  Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease.

Authors:  Gregory W Munson; Kenneth A Wallston; Robert S Dittus; Theodore Speroff; Christianne L Roumie
Journal:  J Gen Intern Med       Date:  2009-05-15       Impact factor: 5.128

9.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 10.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.